Patents by Inventor Helen Francis-Lang

Helen Francis-Lang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IGs as modifiers of the p53 pathway and methods of use
    Publication number: 20030087266
    Abstract: Human IG genes are identified as modulators of the p53 pathway, and thus are therapeutic targets for disorders associated with defective p53 function. Methods for identifying modulators of p53, comprising screening for agents that modulate the activity of IG are provided.
    Type: Application
    Filed: June 3, 2002
    Publication date: May 8, 2003
    Inventors: Lori Friedman, Gregory D. Plowman, Marcia Belvin, Helen Francis-Lang, Danxi Li, Roel P. Funke, Mario N. Lioubin
  • P5CRs as modifiers of the p53 pathway and methods of use
    Publication number: 20030036078
    Abstract: Human P5CR genes are identified as modulators of the p53 pathway, and thus are therapeutic targets for disorders associated with defective p53 function. Methods for identifying modulators of p53, comprising screening for agents that modulate the activity of P5CR are provided.
    Type: Application
    Filed: June 3, 2002
    Publication date: February 20, 2003
    Inventors: Lori Friedman, Gregory D. Plowman, Marcia Belvin, Helen Francis-Lang, Danxi Li, Roel P. Funke, Stefan Engst
  • CADs as modifiers of the p53 pathway and methods of use
    Publication number: 20030036076
    Abstract: Human CAD genes are identified as modulators of the p53 pathway, and thus are therapeutic targets for disorders associated with defective p53 function. Methods for identifying modulators of p53, comprising screening for agents that modulate the activity of CAD are provided.
    Type: Application
    Filed: June 3, 2002
    Publication date: February 20, 2003
    Inventors: Lori Friedman, Gregory D. Plowman, Marcia Belvin, Helen Francis-Lang, Danxi Li, Roel P. Funke
  • HPRP4s as modifiers of the p53 pathway and methods of use
    Publication number: 20030027230
    Abstract: Human hPRP4 genes are identified as modulators of the p53 pathway, and thus are therapeutic targets for disorders associated with defective p53 function. Methods for identifying modulators of p53, comprising screening for agents that modulate the activity of hPRP4 are provided.
    Type: Application
    Filed: August 2, 2002
    Publication date: February 6, 2003
    Inventors: Lori Friedman, Gregory D. Plowman, Tak Hung, Helen Francis-Lang, Danxi Li, Roel P. Funke, Michael Costa
  • SLC7s as modifiers of the p53 pathway and methods of use
    Publication number: 20030027188
    Abstract: Human SLC7 genes are identified as modulators of the p53 pathway, and thus are therapeutic targets for disorders associated with defective p53 function. Methods for identifying modulators of p53, comprising screening for agents that modulate the activity of SLC7 are provided.
    Type: Application
    Filed: June 5, 2002
    Publication date: February 6, 2003
    Inventors: Lori Friedman, Gregory D. Plowman, Marcia Belvin, Helen Francis-Lang, Danxi Li, Roel P. Funke
  • ADSLs as modifiers of the p53 pathway and methods of use
    Publication number: 20030022209
    Abstract: Human ADSL genes are identified as modulators of the p53 pathway, and thus are therapeutic targets for disorders associated with defective p53 function. Methods for identifying modulators of p53, comprising screening for agents that modulate the activity of ADSL are provided.
    Type: Application
    Filed: June 3, 2002
    Publication date: January 30, 2003
    Inventors: Lori Friedman, Gregory D. Plowman, Marcia Belvin, Helen Francis-Lang, Danxi Li, Roel P. Funke, Stefan Engst
  • PRMTs as modifiers of the p53 pathway and methods of use
    Publication number: 20030017489
    Abstract: Human PRMT genes are identified as modulators of the p53 pathway, and thus are therapeutic targets for disorders associated with defective p53 function. Methods for identifying modulators of p53, comprising screening for agents that modulate the activity of PRMT are provided.
    Type: Application
    Filed: June 5, 2002
    Publication date: January 23, 2003
    Inventors: Lori Friedman, Gregory D. Plowman, Marcia Belvin, Helen Francis-Lang, Danxi Li, Roel P. Funke
  • HS2STs as modifiers of the p53 pathway and methods of use
    Publication number: 20030013144
    Abstract: Human HS2ST genes are identified as modulators of the p53 pathway, and thus are therapeutic targets for disorders associated with defective p53 function. Methods for identifying modulators of p53, comprising screening for agents that modulate the activity of HS2ST are provided.
    Type: Application
    Filed: June 3, 2002
    Publication date: January 16, 2003
    Inventors: Lori Friedman, Gregory D. Plowman, Marcia Belvin, Helen Francis-Lang, Danxi Li, Roel P. Funke
  • PIBs as modifiers of the p53 pathway and methods of use
    Publication number: 20020192695
    Abstract: Human PIB genes are identified as modulators of the p53 pathway, and thus are therapeutic targets for disorders associated with defective p53 function. Methods for identifying modulators of p53, comprising screening for agents that modulate the activity of PIB are provided.
    Type: Application
    Filed: June 3, 2002
    Publication date: December 19, 2002
    Inventors: Lori Friedman, Gregory D. Plowman, Marcia Belvin, Helen Francis-Lang, Danxi Li, Roel P. Funke